A doping optimization model towards lower loss and higher efficiency at the target operating current is investigated. This model considers the effect of doping concentration on the series resistance and the internal loss. 780 nm lasers doped with a normal doping profile (Dop_normal) and an optimized doping profile (Dop_optimize) are both designed and fabricated. After doping optimization, the power loss decreased by 17%, the output power of the lasers increased by 26% and the electro-optical conversion efficiency increased by 22%. The model provides significant theoretical guidance for the optimization of the laser doping.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1364/OE.493792 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
In Situ Slow-Release Hydrogen Sulfide Therapeutics for Advanced Disease Treatments.
Small
January 2025
Department of Neurosurgery, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510260, China.
Hydrogen sulfide (HS) gas therapygarners significant attention for its potential to improve outcomes in various disease treatments. The quantitative control of HS release is crucial for effective the rapeutic interventions; however, traditional researchon HS therapy frequently utilizes static release models and neglects the dynamic nature of blood flow. In this study, we propose a novel slow-release in-situ HS release model that leverages the dynamic hydrolysis of HS donorswithin the bloodstream.
View Article and Find Full Text PDFCoherent Strain-Inhibiting Phase Construction of Lithium-Rich Manganese-Based Oxide Toward High Mechanochemical Stability.
J Am Chem Soc
January 2025
Chemical Sciences and Engineering Division, Argonne National Laboratory, Lemont, Illinois 60439, United States.
A layered lithium-rich manganese-based oxide cathode, containing 3̅ (LiTMO, TM = Mn, Ni, Co) and 2/ (LiMnO) nanodomains, utilizes both transition metals and oxygen redox to yield substantial energy density. However, the inherent heterogeneous nature and distinct nanodomain redox chemistries of layered lithium-rich oxides will inevitably cause pernicious lattice strain and structural displacement, which can hardly be eliminated by conventional doping or coating strategies and result in accelerated performance decay. Herein, we incorporate a strain-inhibiting perovskite phase coherently grown within the layered structure to effectively restrain the displacement and lattice strain during uneven Li-ion extraction.
View Article and Find Full Text PDFA novel and high-performance tumor inhibitor of La, N co-doped carbon dots for U251 and LN229 cells.
Colloids Surf B Biointerfaces
January 2025
Department of Neurosurgery, The Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University, Ganzhou 341000, China. Electronic address:
To address the medical challenges posed by glioblastoma, a novel and high-performance tumor inhibitor (La@FA-CDs) composed of folic acid and lanthanum nitrate hexahydrate, was successfully synthesized and demonstrated effectiveness in inhibiting the growth of U251 and LN299 cells. The microstructure of La@FA-CDs was extensively analyzed by FTIR, UV-Vis, XPS, TEM, AFM NMR, and nanoparticle size analyzer. The optical and electrical properties of La@FA-CDs were characterized using a fluorescence spectrometer and a zeta potential analyzer.
View Article and Find Full Text PDFCreating chromaticity palettes and identifying white light emitters through nanocrystal megalibraries.
Sci Adv
January 2025
Department of Chemistry, Northwestern University, Evanston, IL 60201, USA.
Halide perovskites are used to fabricate energy-efficient optoelectronic devices. Determining which compositions yield desired chromatic responses is challenging, especially when doping strategies are used. Here, we report a way of mapping the compositional space of halide perovskites to generate a light emission or "chromaticity" palette.
View Article and Find Full Text PDFDetection of LGD-4033 Metabolites in Camel Urine, Plasma, and Hair Following Oral Administration for Doping Control.
Rapid Commun Mass Spectrom
April 2025
Camel Forensic Laboratory, Central Veterinary Research Laboratory, Dubai, UAE.
Rationale: LGD-4033, a selective androgen receptor modulator (SARM), is recognized for promoting muscle growth and enhancing athletic performance. Its potent anabolic effects have led to its prohibition in both human and animal sports. Although initial in vitro studies have offered insights into its metabolism, an in-depth in vivo analysis is necessary to fully understand its metabolic pathways.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!